Beta-Cell Function and Sitagliptin Trial (BEST)

Clinical trial NCT00420511 · COMPLETED

Trial details

NCT number: NCT00420511
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2007-01-01
Primary completion: 2009-09-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.